The law that created ASTP as a formal federal agency gave it duties such as supporting a more effective marketplace and greater competition. Stephen Konya, ASTP’s chief, innovation and strategic ...

From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference.

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

When it comes to healthcare, simplifying payments offers clear benefits: improved operational efficiency, better cash flow management, and stronger relationships between health plans, providers ...

Healthcare costs are a top concern across the United States, with 2025 anticipated to be the most expensive year for employer-sponsored insurance yet. Employers are expected to face an 8 to 9% ...

FibroGen secured regulatory approvals for roxadustat in China and Europe, but the FDA rejected the drug and asked for another clinical trial. By selling its China business to AstraZeneca, FibroGen ...

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

Steve Muth, like many in the healthcare space, launched ZEM Life for personal reasons. ZEM Life has built a smartwatch, which it’s currently seeking FDA approval for, that will be able to ...

In an interview with MedCity News, Smarter Technologies CEO Jeremy Delinsky talked about the newly formed business Smarter Technologies and his ambition to automate hospitals' revenue management ...

The only way to achieve clinical AI adoption at scale is to design products that serve doctors in a way that feels natural and personalized, according to one startup CEO. This was a claim made by ...